EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Screening of BRCA1 and BRCA2 germline mutations in unselected triple‐negative breast cancer patients: A series from north of Morocco

Mohammed Mansouri, Touria Derkaoui, Joaira Bakkach, Ali Loudiyi, Naima Ghailani Nourouti, Amina Barakat, Jaime Martínez de Villarreal, Carlos Cortijo Bringas, Mohcine Bennani Mechita

Precision Medical Sciences · 2020

DOI: 10.1002/prm2.12009 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Triple‐negative breast cancer (TNBC) is strongly associated with BRCA1 and BRCA2 germline pathogenic variants. Revised NCCN guidelines recommend that TNBC patients ≤60 years of age should be referred for genetic counseling and consideration of BRCA1/2 testing. The aim of the present study is to characterize germline BRCA1 and BRCA2 variants in a series of TNBC patients from the north of Morocco. Methods We analyzed BRCA1 and BRCA2 genes by next generation sequencing in a cohort of 32 patients unselected for family history and age of diagnosis. Results Among 32 patients with TNBC, 7 carried a pathogenic BRCA1 or BRCA2 variant (21.87%). Six patients carried a pathogenic BRCA1 variant and one carried a pathogenic BRCA2 variant. Overall, six different pathogenic BRCA1 or BRCA2 variants were identified, including frameshift, nonsense, and missense variants. The BRCA1 missense c.5309G>T, a founder pathogenic variant in the Moroccan population, was identified in two unrelated patients. In addition, six variants of unknown clinical significance were identified. Conclusions The understanding of BRCA1 and BRCA2 status in TNBC patients plays an important role in optimizing the preventive and therapeutic management. Despite the small size of our cohort, we believe that this work would help broaden our knowledge of TNBC and BRCA1/2 variants in Morocco.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →